Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis

Oncogene volume 18, pages 4689–4698 (1999)Cite this article

Abstract

p27Kip1 and p21Cip1 are cyclin dependent kinase inhibitors which can arrest cell proliferation and p27 is a tumor suppressor gene. To address the mechanism of tumor suppression by p27 and to determine if p21 has a tumor suppressor phenotype, we utilized the two stage skin carcinogenesis model on p27 and p21 knockout mice. In this model, initiation, which involves mutation of H-ras induced by DMBA, can be distinguished from promotion induced by TPA, and progression to carcinoma. The mean number of papillomas did not differ between p27−/− and control littermates, but papilloma growth rate was increased and carcinomas developed earlier. Thus, p27 deficiency did not enhance initiation, but resulted in more rapid clonal expansion of initiated cells during promotion. TPA treatment reduced p27 expression in keratinocytes also supporting a role for p27 during promotion. Tumors from p27−/− mice contained mutant H-ras indicating that p27 deficiency did not substitute for mutant ras and further, that during ras driven tumor growth, p27 is partially antagonistic since its removal led to faster growth. The treated p27−/− mice also developed intestinal adenomas. p21−/− mice did not display a significant increase in tumor numbers, growth rate or progression to carcinomas and these tumors also had mutated H-ras. Carcinomas from p21−/− mice were more poorly differentiated with a high frequency of anaplastic spindle cell carcinomas. Thus p21 deficiency mainly resulted in higher grade undifferentiated tumors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Aktas H, Cai H and Cooper GM. . 1997 Mol. Cell. Biol. 17: 3850–3857.

  • Bailleul B, Surani MA, White S, Barton SC, Brown K, Blessing M, Jorcano J and Balmain A. . 1990 Cell 62: 697–708.

  • Bremner R and Balmain A. . 1990 Cell 61: 407–417.

  • Brown K, Quintanilla M, Ramsden M, Kerr IB, Young S and Balmain A. . 1986 Cell 46: 447–456.

  • Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T and Hannon GJ. . 1995 Nature 377: 552–557.

  • Buchmann A, Ruggeri B, Klein-Szanto AJP and Balmain A. . 1991 Cancer Res. 51: 4097–4101.

  • Burns PA, Kemp CJ, Gannon JV, Lane DP, Bremner R and Balmain A. . 1991 Oncogene 6: 2363–2369.

  • Casaccia-Bonnefil P, Tikoo R, Kiyokawa H, Friedrich Jr, V, Chao MV and Koff A. . 1997 Genes Dev. 11: 2335–2346.

  • Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari, L, Sandhu C, Shaw P, Yeger H, Morava-Protzner I, et al. 1997 Nature Med. 3: 227–230.

  • Deng C, Zhang P, Harper JW, Elledge SJ and Leder P. . 1995 Cell 82: 675–684.

  • Di Cunto F, Topley G, Calautti E, Hsiao J, Ong L, Seth, PK and Dotto GP. . 1998 Science 280: 1069–1072.

  • Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr, CA, Butel JS and Bradley A. . 1992 Nature 356: 215–221.

  • Durand B, Gao FB and Raff M. . 1997 EMBO 16: 306–317.

  • El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Mercer WE, Kinzler KW and Vogelstein B. . 1993 Cell 75: 817–825.

  • El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, et al. 1994 Cancer Res. 54: 1169–1174.

  • El-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu, VE, Burrell M, Hill DE, Healy E, Rees JL, et al. 1995 Cancer Res. 55: 2910–2919.

  • Esposito V, Baldi A, De Luca A, Groger AM, Loda M, Giordano GG, Caputi M, Baldi F, Pagano M and Giordano A. . 1997 Cancer Res. 57: 3381–3385.

  • Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, et al. 1996 Cell 85: 733–744.

  • Fero ML, Randel E, Gurley KE, Roberts JM and Kemp CJ. . 1998 Nature 396: 177–180.

  • Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, BeachD and Lassar AB. . 1995 Science 267: 1018–1021.

  • Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ. . 1993 Cell 75: 805–816.

  • Harvat BL, Wang A, Seth P and Jetten AM. . 1998 J. Cell Sci. 111: 1185–1196.

  • Hauser PJ, Agrawal D, Flanagan M and Pledger WJ. . 1997 Cell Growth Differ. 8: 203–211.

  • Hunter T and Pines J. . 1994 Cell 79: 573–582.

  • Jiang H, Lin J, Su ZZ, Collart FR, Huberman E and Fisher PB. . 1994 Oncogene 9: 3397–3406.

  • Kalbfleish JD, Prentice HM. . 1980 The Statistical Analysis of Failure Time Data. New York: Wiley.

    Google Scholar 

  • Kamb A. . 1995 Trends Genetics 11: 136–140.

  • Kawada M, Yamagoe S, Murakami Y, Suzuki K, Mizuno S and Uehara Y. . 1997 Oncogene 15: 629–637.

  • Kemp CJ, Donehower LA, Bradley A and Balmain A. . 1993 Cell 74: 813–822.

  • Klein-Szanto AJP. . 1989 Carcinogenesis, Vol.11. In: Skin Tumors:Experimental and Clinical Aspects. Conti CJ, Slaga TJ and Klein-Szanto AJP (ed). Raven Press: New York pp. 19–53.

    Google Scholar 

  • Kranenburg O, Scharnhorst V, van der Eb AJ and Zantema A. . 1995 J. Cell Biol. 131: 227–234.

  • Levine AJ. . 1997 Cell 88: 323–331.

  • Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta, GF, Jessup JM and Pagano M. . 1997 Nature Med. 3: 231–234.

  • Missero C, Di Cunto F, Kiyokawa H, Koff A and Dotto GP. . 1996 Genes Deve. 10: 3065–3075.

  • Mori M, Mimori K, Shiraishi T, Tanaka S, Ueo H, Sugimachi K, and Akiyoshi T. . 1997 Nature Medi. 3: 593.

  • Nakanishi M, Robertorge RS, Adami GR, Periera-Smith OM and Smith JR. . 1995 EMBO 14: 555–563.

  • Noda A, Ning Y, Venable SF, Pereira-Smith OM and Smith JR. . 1994 Exp. Cell Res. 211: 90–98.

  • Olson MF, Paterson HF and Marshall CJ. . 1998 Nature 394: 295–299.

  • Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW and Elledge SJ. . 1995 Science 267: 1024–1027.

  • Pietenpol JA, Bohlander SK, Sato Y, Papadopoulos N, Liu B, Friedman C, Trask BJ, Roberts JM, Kinzler KW, Rowley JD, et al. 1995 Cancer Res. 55: 1206–1210.

  • Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P and Massague J. . 1994 Cell 78: 59–66.

  • Ponce-Castaneda MV, Lee MH, Latres E, Polyak K, Lacombe L, Montgomery K, Mathew S, Krauter K, Sheinfeld J, Massague J, et al. 1995 Cancer Res. 55: 1211–1214.

  • Ponten F, Berne B, Ren ZP, Nister M and Ponten J. . 1995 J. Invest. Dermatol. 105: 402–406.

  • Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR and Roberts JM. . 1997 Nature Medi. 3: 222–225.

  • Quintanilla M, Brown K, Ramsden M and Balmain A. . 1986 Nature 322: 78–80.

  • Ruggeri B, Caamano J, Goodrow T, DiRado M, Bianchi A, Trono D, Conti CJ and Klein-Szanto AJP. . 1991 Cancer Res. 51: 6615–6621.

  • Schreiber E, Matthias P, Muller MM and Schaffner W. . 1989 Nucleic Acids Res. 17: 6419.

  • Sewing A, Wiseman B, Lloyd AC and Land H. . 1997 Mol. Cell. Biol. 17: 5588–5597.

  • Sherr CJ and Roberts JM. . 1995 Genes Deve. 9: 1149–1163.

  • Shiohara M, El-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Vogelstein B and Koeffler HP. . 1994 Blood 84: 3781–3784.

  • Singh SP, Lipman J, Goldman H, Ellis Jr, FH, Aizenman L, Cangi MG, Signoretti S, Chiaur DS, Pagano M and Loda M. . 1998 Cancer Res. 58: 1730–1735.

  • St. Croix B, Florenes VA, Rak JW, Flanagan M, Bhattacharya N, Slingerland JM and Kerbel RS. . 1996 Nature Medi. 2: 1204–1210.

  • Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA and El-Houseini ME. . 1994 Oncogene 9: 3389–3396.

  • Takuwa N and Takuwa Y. . 1997 Mol. Cell. Biol. 17: 5348–5358.

  • Tikoo R, Casaccia-Bonnefil P, Chao MV and Koff A. . 1997 J. Biol. Chem. 272: 442–447.

  • Toyoshima H and Hunter T. . 1994 Cell 78: 67–74.

  • Tsihlias J, Kapusta LR, DeBoer G, Morava-Protzner I, Zbieranowski I, Bhattacharya N, Catzavelos GC, Klotz LH and Slingerland JM. . 1998 Cancer Res. 58: 542–548.

  • Weinberg WC, Montano NE and Deng C. . 1997 Oncogene 15: 685–690.

  • Winberg LD, Budunova IV, Warren BS, et al. 1995 Skin Cancer: Mechanisms and Human Relevance. Mukhtar H (ed.).. CRC Press, Inc: Boca Raton pp. 113–20.

    Google Scholar 

  • Woods D, Parry D, Cherwinski H, Bosch E, Lees E and McMahon M. . 1997 Mol.Cell. Biol. 17: 5598–5611.

  • Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D. . 1993 Nature 366: 701–704.

  • Zeng YX, Somasundaram K and El-Diery WS. . 1997 Nature Genet. 15: 78–82.

Download references

Acknowledgements

We thank James Roberts and Philip Leder for providing the p27 and p21 knockout mice, Shaoli Sun for advice with pathology, Hartmut Richter for communicating unpublished results and our colleagues at the Fred Hutchinson Cancer Center for insightful comments. J Philipp was supported by grants from the ‘Swiss National Science Foundation’, and by the ‘Krebsforschung Schweiz’. This work was funded by an ACS research grant to CJ Kemp.

Author information

Authors and Affiliations

  1. Fred Hutchinson Cancer Research Center, 1100 Fairview N., Seattle, WA 98109, Washington, USA

    Jeannette Philipp, Khoa Vo, Kay E Gurley, Kristy Seidel & Christopher J Kemp

Authors
  1. Jeannette Philipp
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Khoa Vo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kay E Gurley
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kristy Seidel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christopher J Kemp
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Philipp, J., Vo, K., Gurley, K. et al. Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis. Oncogene 18, 4689–4698 (1999). https://doi.org/10.1038/sj.onc.1202840

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202840

Keywords

This article is cited by

Search

Advanced search

Quick links